AXCYNSIS THERAPEUTICS PTE. LTD.
Country of registration | Singapore |
Registration number | 202205879C |
Local SIC | |
Incorporation date | 21 Feb 2022 |
Company age | 4 years 4 months |
Official entity type | Private Limited Company |
No. of officers | 9 |
Contact
41 SCIENCE PARK ROAD, #04-18, THE GEMINI, Singapore 117610
This is the legal entity page of AXCYNSIS THERAPEUTICS PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- AXCYNSIS THERAPEUTICSView MoreSingaporeAxcynsis Therapeutics Pte. Ltd. is a platform-based biotech company dedicated to creating novel antibody-conjugate (AXC) therapies to transform cancer care. By harnessing proprietary technologies, we are building a diverse portfolio of AXC candidates with the potential to address unmet medical needs and provide new treatment options.
Revenue | < 1m |
Share Capital - Ordinary shares | USD 18,000 |
Share Capital - Preference shares | USD 15,000,000 |
Frequently Asked Questions (FAQ)
- What is the address of AXCYNSIS THERAPEUTICS PTE. LTD.?
- Where is AXCYNSIS THERAPEUTICS PTE. LTD.'s headquarter?
- What is AXCYNSIS THERAPEUTICS PTE. LTD.'s contact number?
- What AXCYNSIS THERAPEUTICS PTE. LTD.'s spending power?
- Does AXCYNSIS THERAPEUTICS PTE. LTD. have a presence in the domain it operates in?

